Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.
J Immunother Cancer. 2021 Apr;9(4):e001705. doi: 10.1136/jitc-2020-001705.
J Immunother Cancer. 2021.
PMID: 33833048
Free PMC article.
Clinical Trial.
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas.
Rodríguez-Remírez M, Del Puerto-Nevado L, Fernández-Aceñero MJ, Cruz-Ramos M, García-García L, Solanes S, Molina-Roldán E, García-Foncillas J, Cebrián A.
Rodríguez-Remírez M, et al. Among authors: solanes s.
Neuroendocrinology. 2021;111(1-2):146-157. doi: 10.1159/000506163. Epub 2020 Jan 28.
Neuroendocrinology. 2021.
PMID: 31991407
Item in Clipboard
Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study.
Rodríguez-Remírez M, Del Puerto-Nevado L, Fernández Aceñero MJ, Ebrahimi-Nik H, Cruz-Ramos M, García-García L, Solanes S, Baños N, Molina-Roldán E, García-Foncillas J, Cebrián A.
Rodríguez-Remírez M, et al. Among authors: solanes s.
Neuroendocrinology. 2020;110(1-2):50-62. doi: 10.1159/000500591. Epub 2019 Apr 29.
Neuroendocrinology. 2020.
PMID: 31030198
Item in Clipboard
Cite
Cite